New urine test could spare bladder cancer patients from painful scopes

NCT ID NCT03193515

Recruiting now Diagnosis Sponsor: Cedars-Sinai Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new urine test that might find returning bladder cancer earlier and more accurately than current urine tests. The goal is to see if this test can reduce the need for cystoscopy, a procedure where a tiny camera is inserted into the bladder. About 300 adults with a history of bladder cancer will provide urine samples during their regular check-ups. If successful, this could make cancer surveillance much easier and less invasive.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infiltrating bladder urothelial carcinoma non-invasive bladder urothelial carcinoma urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER

Contacts and locations

Locations

Cedars-Sinai Medical Center
RECRUITING

Los Angeles, California, 90048, United States
Kyoto University Graduate School of Medicine
RECRUITING

Kyoto, Japan
UT Southwestern Medical Center at Dallas
ACTIVE_NOT_RECRUITING

Dallas, Texas, 75390, United States
University of California San Francisco
ACTIVE_NOT_RECRUITING

San Francisco, California, 94158, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.